ACTUALIZA 3-Novavax retrasa su objetivo de rentabilidad hasta 2029; las acciones caen
ACTUALIZA 3-Novavax retrasa su objetivo de rentabilidad hasta 2029; las acciones caen Novavax espera
Related stories
BRIEF-Lifetech Scientific Terminates Framework Agreement
BRIEF-Lifetech Scientific Terminates Framework Agreement Nov 5 (Reuters) - LifeTech Scientific Corp
L impact | EQUITY | Nov 05, 2026, 04:42 PM UTC
Lifetech Scientific Terminates Framework Agreement
LifeTech Scientific Corp HKEX:1302
L impact | EQUITY | Nov 05, 2026, 04:42 PM UTC
MERCATI IN TEMPO REALE-Azioni in calo il giorno dopo il rally post-elettorale; Nasdaq giù del 4%
MERCATI IN TEMPO REALE-Azioni in calo il giorno dopo il rally post-elettorale; Nasdaq giù del 4% Agg
L impact | EQUITY | Nov 05, 2026, 04:42 PM UTC
Breton Technology Says Chairman Increases H Shareholding Up To HK$50 Mln
Breton Technology Co Ltd HKEX:1333
L impact | EQUITY | Nov 05, 2026, 04:42 PM UTC
BRIEF-Breton Technology Says Chairman Increases H Shareholding Up To HK$50 Mln
BRIEF-Breton Technology Says Chairman Increases H Shareholding Up To HK$50 Mln Nov 5 (Reuters) - Bre
L impact | EQUITY | Nov 05, 2026, 04:42 PM UTC
REG-Plesio: Report de la publication de l’activité du T3 2026
Plesio: Report de la publication de l’activité du T3 2026 Report de la publication de l’activité du
L impact | EQUITY | Nov 05, 2026, 04:42 PM UTC